Effect of alpha- and beta-blocking drugs on the clotting and fibrinolytic response to venous status in man.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D001775:Blood Circulation; D001777:Blood Coagulation / Q000187:drug effects*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012712:Serum Globulins; D013925:Thromboplastin / Q000032:analysis; D013997:Time Factors; D014111:Tourniquets
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D012712:Serum Globulins; D005165:Factor V; D005167:Factor VII; D005169:Factor VIII; D005170:Factor X; D013925:Thromboplastin; D011433:Propranolol; D010646:Phentolamine